1.Isolation and Identification of Seven Symbiotic Bacteria from Local Entomopathogenic Nematodes
Xiu-Fen YANG ; Zheng LIU ; Ran ZHANG ; Huai-Wen YANG ; Jing-Jing YUAN ; Heng JIAN ;
Microbiology 1992;0(02):-
The symbiotic bacterium exists in the intestines of entomopathogenic nematodes and is a potential biological agent.Systematic classification of these bacteria is scarce in China.In this paper,seven strains of symbiotic bacteria from local entomopathogenic nematodes were identified by both observation of mor-phology,physiological,biochemical characteristics and sequence analysis of 16S rDNA fragments.
2.DNA genotyping of oral epithelial cells by laser capture microdissection.
Li-Hua GU ; Cheng ZHANG ; Lian-Kang CHEN ; Hui-Fen ZHEN ; Li CHENG ; Huai-Gu ZHOU
Journal of Forensic Medicine 2006;22(3):196-203
OBJECTIVE:
The STR genotypping of trace oral epithelial cells which are microdissected by laser capture microdissection system (LCM) is explored.
METHODS:
The oral epithelial cells are microdissected using a low-power infrared laser by VERITAS Microdissection Instrument. STR loci of Profiler Plus are detected by multiplex PCR procesures.
RESULTS:
DNA genotyping of 7-8 oral epithelial cells are succeeded, and DNA genotyping of 3-4 oral epithelial cells are failed.
CONCLUSION
It is viable in genotyping of trace oral epithelial cells by Laser Capture Microdissection as a new technology of seperating single cell.
Cell Separation/methods*
;
DNA/genetics*
;
Epithelial Cells
;
Genotype
;
Humans
;
Lasers
;
Microdissection/methods*
;
Mouth/cytology*
;
Tandem Repeat Sequences
3.Radiomics model based on CT images for distinguishing invasive lung adenocarcinoma with micropapillary or solid structure
Fen WANG ; Teng ZHANG ; Mei YUAN ; Genji BO
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(01):65-70
Objective To investigate the radiomics features to distinguish invasive lung adenocarcinoma with micropapillary or solid structure. Methods A retrospective analysis was conducted on patients who received surgeries and pathologically confirmed invasive lung adenocarcinoma in our hospital from April 2016 to August 2019. The dataset was randomly divided into a training set [including a micropapillary/solid structure positive group (positive group) and a micropapillary/solid structure negative group (negative group)] and a testing set (including a positive group and a negative group) with a ratio of 7∶3. Two radiologists drew regions of interest on preoperative high-resolution CT images to extract radiomics features. Before analysis, the intraclass correlation coefficient was used to determine the stable features, and the training set data were balanced using synthetic minority oversampling technique. After mean normalization processing, further radiomics features selection was conducted using the least absolute shrinkage and selection operator algorithm, and a 5-fold cross validation was performed. Receiver operating characteristic (ROC) curves were depicted on the training and testing sets to evaluate the diagnostic performance of the radiomics model. Results A total of 340 patients were enrolled, including 178 males and 162 females with an average age of 60.31±6.69 years. There were 238 patients in the training set, including 120 patients in the positive group and 118 patients in the negative group. There were 102 patients in the testing set, including 52 patients in the positive group and 50 patients in the negative group. The radiomics model contained 107 features, with the final 2 features selected for the radiomics model, that is, Original_ glszm_ SizeZoneNonUniformityNormalized and Original_ shape_ SurfaceVolumeRatio. The areas under the ROC curve of the training and the testing sets of the radiomics model were 0.863 (95%CI 0.815-0.912) and 0.857 (95%CI 0.783-0.932), respectively. The sensitivity was 91.7% and 73.7%, the specificity was 78.8% and 84.0%, and the accuracy was 85.3% and 78.4%, respectively. Conclusion There are differences in radiomics features between invasive pulmonary adenocarcinoma with or without micropapillary and solid structures, and the radiomics model is demonstrated to be with good diagnostic value.
4.Research status of dual-specificity phosphatase family and embryonic development
Ran ZHANG ; Jing-Suo WANG ; Ya-Fen CHEN ; Shen-Wei LI ; Huai-Can ZHANG ; Wei JI ; Hai-Ying WANG
The Chinese Journal of Clinical Pharmacology 2023;39(24):3664-3668
Embryo development is the main stage of the formation of various tissues,organs and systems.Abnormal embryo development can lead to embryo deformity and even death.Many factors are involved in this process.It was found that dual-specificity phosphatase(DUSP)could regulate the growth and development of different cells through a variety of signaling pathways,and it has been confirmed that the DUSPs family has an important association with embryonic development.A large amount of evidences showed that DUSPs and its downstream mitogen-activated protein kinase(MAPK)pathway played a key role in the regulation of gametogenesis,digestive system development and embryonic ear development.dusp27 is another extremely important gene whose role in early embryonic development remains to be studied,but it plays an important role in the development of embryonic muscle tissue.In this paper,the development of the above systems in DUSPs family was briefly reviewed in order to provide theoretical basis for the treatment of embryonic developmental diseases.
5.Inhibitory effect of diosgenin on experimentally induced benign prostatic hyperplasia in rats.
Jing CHEN ; Huai-Fen ZHANG ; Chao-Mei XIONG ; Jin-Lan RUAN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(6):806-810
This study investigated the effect of diosgenin, a natural sapogenin possessing various pharmacological activities, on benign prostatic hyperplasia (BPH) in rats and the possible mechanisms. BPH was established in the castrated rats by subcutaneous injection of testosterone propionate. Animals were randomly divided into four groups (n=10 each): model group (0.5% sodium carboxymethyl cellulose); positive control group (3 mg/kg finasteride); two diosgenin groups (50 and 100 mg/kg). The drugs were intragastricaly given in each group for consecutive 3 weeks. Another 10 rats with no testicles cut off served as negative controls and they were subcutaneously injected with 0.1 mL olive oil per day and then treated with 0.5% sodium carboxymethylcellulose. After 3-week administration, the prostate index and serum PSA level were determined, and histopathological examination was carried out. The levels of MDA, SOD and GPx in prostates were also measured. Additionally, the expression of Bcl-2, Bax and p53 was examined using Western blotting. The results showed that the prostate index and serum PSA level were significantly decreased, and the pathological changes of the prostate gland were greatly improved in diosgenin groups as compared with the model group. Elevated activities of SOD and GPx, and reduced MDA level were also observed in diosgenin-treated rats. In addition, the expression of Bcl-2 in prostates was down-regulated, whereas that of Bax and p53 was up-regulated in diosgenin-treated rats. These results indicated that diosgenin was effective in inhibiting testosterone propionate-induced prostate enlargement and may be a candidate agent for the treatment of BPH.
Animals
;
Apoptosis
;
Diosgenin
;
pharmacology
;
therapeutic use
;
Glutathione Peroxidase
;
metabolism
;
Male
;
Malondialdehyde
;
metabolism
;
Oxidative Stress
;
Prostate
;
drug effects
;
metabolism
;
Prostate-Specific Antigen
;
blood
;
Prostatic Hyperplasia
;
drug therapy
;
Proto-Oncogene Proteins c-bcl-2
;
metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Superoxide Dismutase
;
metabolism
;
Tumor Suppressor Protein p53
;
metabolism
;
bcl-2-Associated X Protein
;
metabolism
6.Expression and clinical significance of Endostatin, vascular endothelial growth factor and fibroblast growth factor basic-2 in laryngeal carcinoma.
Wei-wei LIU ; Shu-jun ZHANG ; Guang-huai HAN ; Hui-jing SHI ; Jun-ge WANG ; Shu-ling DONG ; Hong-xia LI ; Guo-li LI ; Qi-fen SUN
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2007;42(9):687-691
OBJECTIVETo evaluate the expression and clinical significance of Endostatin, vascular endothelial growth factor (VEGF) and fibroblast growth factor basic-2 (FGF-2) in the laryngeal squamous cell carcinoma (LSCC).
METHODSThe expression of Endostatin, VEGF and FGF-2 in 50 specimens of LSCC, 40 specimens of para-carcinoma and 10 specimens of normal laryngeal tissues were examined by Flow cytometry.
RESULTSCompared with para-carcinoma and normal laryngeal tissues, the expression level and positive rate of Endostatin, VEGF, FGF-2 in LSCC were different in statistics (P < 0.05); the expression level and positive rate of endostatin, VEGF, FGF-2 in LSCC are obviously higher than those in para-carcinoma and normal laryngeal tissues. The expression level and positive rate of Endostatin, VEGF, FGF-2 were no difference in statistics between para-carcinoma and normal laryngeal tissues (P > 0.05). The expression level and positive rate of Endostatin, VEGF, FGF-2 in LSCC were associated with lymphoid metastasis and clinical stage, not associated with age, sex and clinical group.
CONCLUSIONSEndostatin, VEGF and FGF-2 play important role in the incidence, development and prognosis of the LSCC.
Adult ; Aged ; Carcinoma, Squamous Cell ; metabolism ; pathology ; Endostatins ; metabolism ; Female ; Fibroblast Growth Factor 2 ; metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; Laryngeal Neoplasms ; metabolism ; pathology ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Vascular Endothelial Growth Factor A ; metabolism
7.Risk Assessment of MOAH and MOSH in Infants and Young Children.
Lei ZHU ; Hong ZHANG ; Yan Fen CHEN ; Jing Jing PAN ; Ai Dong LIU ; Feng PAN ; Jian Bo ZHANG ; Huai Ning ZHONG
Biomedical and Environmental Sciences 2019;32(2):130-133
Bread
;
analysis
;
Child, Preschool
;
Dietary Exposure
;
analysis
;
Flour
;
analysis
;
Food Additives
;
analysis
;
Food Contamination
;
analysis
;
Food, Preserved
;
analysis
;
Humans
;
Hydrocarbons
;
analysis
;
Infant
;
Infant Formula
;
analysis
;
Infant, Newborn
;
Risk Assessment
8.Clinical Significance of Minimal Residual Disease in Risk Stratification and Prognosis of Childhood B-lineage Acute Lymphoblastic Leukemia.
Fen-Yan AN ; Shu-Hong ZHANG ; Ling-Jun KONG ; Ying LIANG ; Ji-Xin XU ; Hai-Long HE ; Yi-Huai CHAI ; Wen-Li ZHAO
Journal of Experimental Hematology 2017;25(3):729-735
OBJECTIVETo explore clinical significance of monitoring the level of minimal residual disease (MRD) at different time point in the risk stratification and prognosis of Childhood B-lineage Acute Lymphoblastic Leukemia.
METHODSThree hundred and eighty cases of children's B-ALL from Augest 2008 to January 2013 in our hospital were enrolled in this study. MRD levels were detected at day 15, day 33 and week 12 after initial chemotherapy. The event-free survival(EFS) and overall survival (OS) were measured on the basis of MRD levels at different stages of chemotherapy and were compared by Kaplan Meier analyses.
RESULTSThe patient's age, initial white blood cell count, chromosome, MLL, BCR/ABL, pretreatment reaction, bone marrow MRD at days 33 were closely related with the 5-year EFS rate. Multiparameter flow cytometry showed the marked MRD and unmarked MRD were not significantly different between their 5-year EFS rate(P>0.05), and the every immune phenotype was also no significantly different between the 5-year EFS rate(P>0.05). The children with MRD≥10at day 15(P<0.01), MRD≥10at day 33 (P<0.01) and MRD≥10on week 12(P<0.01) have a decreased 5-year EFS rate and overall survival, which related with poor prognosis obviously. The 5-year EFS rates at the MRD<10(negative), 10-10, 10-10and ≥10at day 33 were 86.6±2.7%, 77.5±4.9%, 70.1±8.0%, and 44.8±9.9%(P<0.01) with significant difference respectively; the 5-year OS rate was 89.5±2.7%, 80±4.9%, 76.0±7.8%, and 53.2±10.1% with statistically significant difference(P<0. 01).
CONCLUSIONThe MRD≥10at day 33 is a high risk factor for significant reduction of the 5-year EFS rate and the 5-year OS rate of children with B-ALL. Thus, dynamic monitoring the MRD level can predict relapse of B-ALL after remission.
9.Clinical analysis of acute heart failure's risk factor for chronic myelogenous leukemia patient during the early stage of allogeneic hematopoietic stem cell transplantation.
Ke-Feng SHEN ; Qian-Li JIANG ; Qi-Fa LIU ; Jing SUN ; Huai-Ming WANG ; Dan XU ; Yu ZHANG ; Zhi-Ping FAN ; Fen HUANG ; Hong-Sheng ZHOU ; Xiao-Fang LI ; Yong-Qiang WEI ; Min DAI ; Fan-Yi MENG ; Mo YANG
Journal of Experimental Hematology 2015;23(1):178-182
OBJECTIVEThe study was to analyze the acute heart failure's risk factors and clinical characteristics for the patient with chronic myelogenous leukemia (CML) during the early stage (within 100 d) of allogeneic hematopoietic stem cell transplantation (allo-HSCT).
METHODSA total of 106 cases of CML received allo-HSCT were retrospectively studied in Nanfang Hospital from May 2003 to May 2013. On the basis of existence or absence of acute heart failure during early stage of allo-HSCT (100 d), the patients were divided into heart failure (15 cases) and control group (91 cases). Using Logistic univariate analysis, Fisher' exact test and Pearson X(2) test, the acute heart failure's risk factors and clinical characteristics of both groups were analyzed.
RESULTSThe median occurrence time of acute heart failure was 3 d (1 d before transplantation to 84 d after transplantation). Logistic univariate analysis indicated that the imatinib treatment history and time, and the prophylaxis regimens for GVHD with anti-thymocyte globulin (ATG) were all the poor prognostic factors for acute heart failure. Incidence of hepatic veno-occlusive disease (HVOD), bacterial infection and adverse prognostic events including death in the heart failure group patients were statistically higher than that in control group (P < 0.05).
CONCLUSIONAcute heart failure mostly happened in the early stage after allo-HSCT, imatinib treatment and GVHD prophylaxis regimens with ATG are the poor prognostic factors for acute heart failure. The patients of heart failure group seem to have higher incidence of hepatic veno-occlusive disease (HVOD), bacterial infection and deaths.
Acute Disease ; Allografts ; Antilymphocyte Serum ; Benzamides ; Heart Failure ; Hematopoietic Stem Cell Transplantation ; Hepatic Veno-Occlusive Disease ; Humans ; Imatinib Mesylate ; Incidence ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive ; Piperazines ; Pyrimidines ; Retrospective Studies ; Risk Factors